Pacer Advisors Inc. Raises Holdings in Colgate-Palmolive Company $CL

Pacer Advisors Inc. boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 3,052.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,697,047 shares of the company’s stock after buying an additional 2,611,485 shares during the period. Pacer Advisors Inc.’s holdings in Colgate-Palmolive were worth $215,602,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $960,390,000. Schroder Investment Management Group raised its holdings in Colgate-Palmolive by 242.3% in the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after purchasing an additional 3,768,784 shares in the last quarter. Acadian Asset Management LLC lifted its position in shares of Colgate-Palmolive by 42.9% during the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock valued at $556,663,000 after buying an additional 1,839,853 shares during the last quarter. OMERS ADMINISTRATION Corp boosted its holdings in shares of Colgate-Palmolive by 2,890.5% in the 2nd quarter. OMERS ADMINISTRATION Corp now owns 1,417,542 shares of the company’s stock valued at $128,855,000 after buying an additional 1,370,140 shares in the last quarter. Finally, Laurel Wealth Advisors LLC grew its position in shares of Colgate-Palmolive by 8,989.7% in the 2nd quarter. Laurel Wealth Advisors LLC now owns 1,306,011 shares of the company’s stock worth $118,716,000 after buying an additional 1,291,643 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 0.7%

Shares of CL opened at $80.50 on Friday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The stock has a fifty day simple moving average of $78.49 and a two-hundred day simple moving average of $82.84. The company has a market capitalization of $64.89 billion, a PE ratio of 22.55, a price-to-earnings-growth ratio of 5.72 and a beta of 0.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 1.9% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CL shares. Jefferies Financial Group set a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, December 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research note on Tuesday, December 9th. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, Bank of America lowered their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $88.81.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.